Cano Health, Inc.

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

The submission of this form does not create an attorney-client relationship.

Investigation Details

On November 17, 2023, UBS cut its rating of Cano Health to “Sell”, citing the Company’s deteriorating liquidity position. UBS opined that “elevated third-party medical expenses will have a sustained negative effect on the company’s already challenged liquidity position.”

On this news, Cano’s stock price fell 6.72%, to close at $7.63 per share on November 17, 2023.